SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%Dec 12 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (5341)1/5/2002 5:58:17 PM
From: Cary Salsberg  Read Replies (1) of 52153
 
"About one in five experimental drugs fails in patient trials,..."

This quote was in the article on bioinformatics posted at Silicon Investor referenced in your post.

If the quote is true and the definition of "patient trials" is precisely given, then we would have a powerful tool for "Biotech Valuation".

I wouild appreciate any comments on the quote from experienced biotech investors.

TIA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News